e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
MoSys, Inc. - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Retension Pharmaceuticals, Inc. - Common Stock
(NQ:
RTSN
)
10.51
-2.50 (-19.22%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Retension Pharmaceuticals, Inc. - Common Stock
Retension Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 18, 2026
From
Retension Pharmaceuticals
Via
GlobeNewswire
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
November 05, 2026
From
Retension Pharmaceuticals
Via
GlobeNewswire
InvestorNewsBreaks – Retension Pharmaceuticals, Inc. (NASDAQ: RTSN) Prices Upsized $45 Million Initial Public Offering
October 14, 2026
Via
Investor Brand Network
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.